BioCryst Pharmaceuticals - 株価

BCRX

8.80

毎日の変更:

2.44%

毎年:

210.95%

価格 日 年
Chugai Pharma 5,889.00 87.00 1.50% -44.13%
Daiichi Sankyo 3,648.00 1.00 0.03% -50.70%
Adamas Pharmaceuticals 4.46 -0.07 -1.55% -24.41%
Alnylam Pharmaceuticals 166.36 1.29 0.78% 39.40%
Alexion Pharmaceuticals 156.70 0.05 0.03% 39.28%
BioCryst Pharmaceuticals 8.80 0.21 2.44% 210.95%
ChemoCentryx 62.02 -1.37 -2.16% 51.53%
DBV Technologies 5.66 1.92 51.34% -55.61%
Enanta Pharmaceuticals 46.72 -1.62 -3.35% -20.25%
Gilead Sciences 63.33 0.93 1.49% 0.21%
GlaxoSmithKline 1,413.60 20.20 1.45% -21.81%
Glaxosmithkline 38.30 0.22 0.58% -18.79%
YTE 90.56 -1.48 -1.61% 12.33%
Ionis Pharmaceuticals 60.80 -0.13 -0.21% -1.03%
Intra Cellular Therapies 33.78 -0.36 -1.05% 26.85%
Karyopharm Therapeutics 14.94 -0.38 -2.48% -20.66%
Mirati Therapeutics 214.47 0.72 0.34% 120.13%
Neurocrine Biosciences 107.69 -1.60 -1.46% 1.28%
Novavax 127.43 -2.55 -1.96% 2,565.90%
PTC Therapeutics 68.49 -0.23 -0.33% 30.53%
Ultragenyx Pharmaceutical 137.97 -1.90 -1.36% 126.63%
Regeneron Pharmaceuticals 517.93 0.02 0.004% 34.33%
Roche Holding 316.65 4.60 1.47% -1.34%
Sarepta Therapeutics 90.32 0.42 0.47% -30.68%
Vertex Pharmaceuticals 225.55 -0.57 -0.25% -4.23%
Zogenix 18.64 -0.33 -1.74% -67.06%

価格 日 年
NASDAQ 12998 -114.13 -0.87% 38.92%
Russell 2000 2123 -32.15 -1.49% 24.51%

BCRX:US
資産
現金と同等
流動資産
流動負債
負債
EBIT
EBITDA
従業員
株当たりのEPS利益
自己資本および準備金
売上総利益
債務の支払利息
借入資本
時価総額
当期純利益
営業経費
営業利益
普通株資本
税引前利益
販売収入
販売および管理費
株式
貿易債権者
貿易債務者